US LNG exports surge but will buyers in China turn up?
JUPITER, FL - Safety Shot, Inc. (NASDAQ:SHOT), a wellness and dietary supplement company with a market capitalization of $27.63 million, has announced the record date for the spin-off of its subsidiary Caring Brands, Inc. (SRM). The company’s stock has faced significant headwinds, declining over 80% in the past year. InvestingPro analysis reveals 15+ additional insights about Safety Shot’s performance and outlook. The record date is slated for April 7, 2025, establishing eligibility for stockholders and certain warrant holders to receive shares in the spin-off.
Holders of Safety Shot’s common stock or warrants from the company’s July 2021 public offering will receive one share of Caring Brands Common Stock for every 45 shares held as of the record date. Fractional shares will not be distributed; instead, they will be rounded down to whole shares by ClearTrust, LLC, the appointed distribution agent.
The distribution of shares is contingent upon the effectiveness of Caring Brands’ Registration Statement by the U.S. Securities and Exchange Commission (SEC), the approval of Caring Brands Common Stock’s listing on the Nasdaq Capital Market, and other necessary approvals. The anticipated distribution date is on or about August 9, 2025, with the expectation that Caring Brands Common Stock will begin trading on Nasdaq around April 11, 2025.
Safety Shot, known for developing Sure Shot, the first patented wellness product aimed at lowering blood alcohol content and boosting energy and mood, plans to expand its business-to-business sales throughout 2025. According to InvestingPro data, analysts forecast nearly 189% revenue growth for the current year, though the company maintains a weak Financial Health Score of 1.19. Sure Shot is currently available online and through major retailers.
The company’s communication contains forward-looking statements regarding the timing and benefits of the spin-off. These statements involve risks and uncertainties that could cause actual results to differ materially from those projected. Safety Shot has outlined potential risks in its SEC filings, including its Annual Report on Form 10-K for the year ended December 31, 2024.
Investors and stockholders are advised that the shares of Caring Brands Common Stock cannot be sold or offers to acquire accepted before the Registration Statement becomes effective. Once available, a prospectus may be obtained from the company or the SEC’s website.
This news is based on a press release statement and does not constitute an offer to sell or a solicitation of an offer to buy any securities. Safety Shot has made no commitment to update or supplement forward-looking statements based on new information or future events. InvestingPro data shows the company holds more cash than debt on its balance sheet, and according to Fair Value calculations, the stock appears undervalued at its current price of $0.41. For deeper insights, investors can access the comprehensive Pro Research Report, available exclusively to InvestingPro subscribers.
In other recent news, Safety Shot, Inc. announced a significant financial move by securing $1.29 million through a private investment in public equity (PIPE) deal. This agreement involved the sale of 3.5 million shares at $0.368 each. Additionally, another PIPE deal was finalized earlier, securing $1 million through the issuance of 2,222,222 shares at $0.45 per share. These transactions are strategic efforts by Safety Shot to bolster its financial position, potentially funding operational activities and research and development.
In another development, Safety Shot shared results from a clinical trial demonstrating the effectiveness of its product, Safety Shot®, in reducing the impact of alcohol consumption. The study, published in the Journal of Nutrition and Dietary Supplements, highlighted the product’s ability to lower blood alcohol levels and alleviate hangover symptoms. This positions Safety Shot to capitalize on the growing market for hangover cure products.
Meanwhile, Scandic Hotels Group reported strong financial performance in Q4 2024, with an adjusted EBITDA of SEK 544 million, up from SEK 451 million the previous year. The company also announced a strategic partnership with SAS and plans for tech upgrades. These developments reflect a positive market momentum in the Nordic countries, supporting Scandic’s outlook for future growth.
This article was generated with the support of AI and reviewed by an editor. For more information see our T&C.